XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.1
Convertible Preferred Stock and Stockholders’ Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 11 Months Ended
Sep. 30, 2024
Aug. 31, 2024
Mar. 31, 2024
Mar. 31, 2024
Mar. 31, 2025
Dec. 31, 2024
Nov. 30, 2024
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Gross proceeds (in Dollars)       $ 2,931    
Common stock, shares authorized         545,000,000 545,000,000  
Common stock, shares issued         37,440,510 37,440,510  
Common stock, shares outstanding         37,440,510 37,440,510  
Pre-Funded Warrants [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Warrants outstanding   5,522,207     6,202,207    
Purchase price per share (in Dollars per share)   $ 9.7          
Number of shares issued 680,000            
Purchase price per share (in Dollars per share) $ 22.999            
Expiration date            
Employee Warrants [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Warrants outstanding         3,054,358 3,054,358  
Exercise price per warrant (in Dollars per share)         $ 7.8 $ 7.8  
Employee warrants issued         3,054,358    
Vesting period           4 years  
Paruka Warrant [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Exercise price per warrant (in Dollars per share)           $ 19.39  
Warrant purchase           596,930  
Term of warrant           10 years  
Common Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Warrants exercisable 680,000 5,522,207          
Common stock, shares authorized         545,000,000    
Common stock, shares issued         37,440,510    
Common stock, shares outstanding         37,440,510    
Common Stock [Member] | Pre-Funded Warrants [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Exercise price per warrant (in Dollars per share) $ 0.001 $ 0.01          
Restricted Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Common stock, shares issued         2,207,553    
Common stock, shares outstanding         2,207,553    
Series A Preferred Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Converted shares             2,439,000
Preferred stock, shares outstanding          
Series A Preferred Stock [Member] | Fairmount [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Gross proceeds (in Dollars)     $ 3,000        
Series B Preferred Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Converted shares   137,138          
Preferred stock, shares outstanding         137,138    
Conversion ratio         83.3332:1    
Pre-Merger Oruka [Member] | Series A Preferred Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Issuance costs (in Dollars)     $ 100        
Pre-Merger Oruka [Member] | Series A Preferred Stock [Member] | Fairmount [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Purchase price per share (in Dollars per share)     $ 0.15 $ 0.15      
Number of shares issued     20,000,000        
PIPE Financing [Member] | Series A Preferred Stock [Member]              
Convertible Preferred Stock and Stockholders’ Equity [Line Items]              
Number of shares issued 2,439            
Purchase price per share (in Dollars per share) $ 23,000            
Converted shares             2,439